东诚药业股价涨5.01%，兴业基金旗下1只基金重仓，持有123.49万股浮盈赚取91.38万元

Group 1 - Dongcheng Pharmaceutical's stock increased by 5.01%, reaching 15.50 CNY per share, with a trading volume of 201 million CNY and a turnover rate of 1.78%, resulting in a total market capitalization of 12.781 billion CNY [1] - The company, established on December 31, 1998, and listed on May 25, 2012, specializes in the research, production, and sales of heparin sodium raw materials and chondroitin sulfate [1] - The revenue composition of Dongcheng Pharmaceutical includes 44.16% from raw materials, 36.38% from nuclear medicine products, 13.17% from formulations, and 6.30% from other sources [1] Group 2 - According to data, one fund under Industrial Bank holds Dongcheng Pharmaceutical as a significant investment, with 1.2349 million shares, accounting for 4.65% of the fund's net value, making it the sixth-largest holding [2] - The fund, named Industrial Medical Care A (011466), has a current scale of 261 million CNY and has achieved a year-to-date return of 22.76%, ranking 4158 out of 8154 in its category [2] - The fund has a one-year return of 14.98%, ranking 5070 out of 8046, and has experienced a cumulative loss of 20.27% since its inception [2]